| 1997 |
Albuterol 0.083% Inhalation Solution ANDA approved |
| 1998 |
Applied for Albuterol 0.5% Inhalation Solution ANDA |
| 1998 |
Nephron expanded operations to 56,000 sq. ft. |
| 1999 |
Helping patients breathe easy |
| 2000 |
Alleviating respiratory discomfort |
| 2000 |
S2 Racepinephrine Inhalation Solution launched |
| 2001 |
Swift growth |
| 2001 |
Albuterol 0.5% Inhalation Solution ANDA approved |
| 2001 |
Ipratropium Bromide 0.02% Inhalation Solution ANDA approved |
| 2001 |
Expansion to 76,000 sq.ft. |
| 2001 |
Addition of single vial, bar coded packaging |
| 2002 |
Getting the word out |
| 2002 |
Lou Kennedy comes on board and begins to build marketing sales force |
| 2003 |
Amplifying production |
| 2003 |
Addition of 4 new Blow-Fill-Seal machines increased capacity to 58 million vials per month |
| 2004 |
A breath of fresh air |
| 2004 |
Albuterol 0.042% Inhalation Solution ANDA approved |
| 2005 |
Automation promotes accuracy |
| 2005 |
Launched the Electronic Fill Weights – EBR Manager |
| 2006 |
Keeping up with demand |
| 2006 |
Nephron acquires its first pieces of Bosch high-speed packaging machinery |
| 2007 |
Improving efficiency and speed |
| 2007 |
Ipratropium Bromide 0.5mg/ Albuterol Sulfate 3mg Inhalation Solution (DuoDose) ANDA approved |
| 2007 |
Addition of a High Speed Single Vial Packaging Line – 35,000 vials per hour |
| 2007 |
Advanced Processes and Quality Controls |
| 2008 |
A year of continued growth |
| 2008 |
Manufacturing Facility Expansion: Construction of an additional formulation weigh suite and filling suite |
| 2008 |
Addition of Rommelag BFS Machines to increase capacity by 18 million vials per month |
| 2009 |
Fighting for a level playing field |
| 2009 |
Bill Kennedy hearing before the US House of Representatives on H.R. 1706: Protecting Consumer Access to Generic Drugs Act of 2009 |
| 2010 |
Expanding our reach |
| 2010 |
Albuterol 0.021% Inhalation Solution ANDA approved |
| 2010 |
Nephron expands distribution facilities with the purchase of a warehouse in Phoenix, AZ |
| 2010 |
Murray, KY warehouse expanded to 150,000 sq. ft. |
| 2011 |
A new economic driver for the Midlands |
| 2011 |
Nephron announced that the company would locate its new operations in Lexington County. |
| 2011 |
$313 million investment is expected to generate 707 new jobs. |
| 2012 |
Relief, now OTC |
| 2012 |
Sodium Chloride (hypertonic saline) 3% and 7% launched |
| 2012 |
Nephron SC breaks ground |
| 2012 |
Launch of our first OTC Medication Asthmanefrin |
| 2013 |
Efficiency through automation |
| 2013 |
The fabrication of the new palletizing systems for the lines at Nephron’s South Carolina facility completed |
| 2015 |
After 16 long months, Nephron finally receives full FDA approval |
| 2016 |
Budesonide 0.25mg and 0.5mg received ANDA approval |
| 2016 |
National launch of the Pocket Neb |
| 2017 |
Nephron 503B Outsourcing Facility officially launched |
| 2017 |
Became licensed in all 50 states |
| 2018 |
Released new opioid free alternatives |
| 2018 |
Established free overnight delivery via UPS |
| 2018 |
Reached a total of 900+ employees |
| 2018 |
Launched a $12.5 million expansion |
| 2019 |
Launched an educator program that employs over 860 local teachers |
| 2019 |
Reached a total of 2000+ FTE and PTE employees |
| 2019 |
Added 75,000 square feet of clean room manufacturing space |
| 2019 |
Installed 4 new sterile BFS lines |
| 2020 |
Nephron steps up to respond to COVID-19, seeking FDA approval to ramp up production |
| 2020 |
Opened a CLIA-certified Diagnostics Lab and began COVID-19 testing for employees, families and businesses in the Midlands and across South Carolina |
| 2020 |
Launched production of FDA approved hand sanitizer |
| 2020 |
Broke ground on a historic $215M expansion, including a vaccine production facility |
| 2020 |
Announced plans for a Kennedy Innovation Complex |
| 2020 |
Received FDA approval of an Abbreviated New Drug Application (ANDA) for two new products – 0.9% Sodium Chloride IV Bags, and Ketorolac Tromethamine Injection Vials |
| 2021 |
With the launch of Nephron Nitrile, a glove manufacturing venture, Nephron begins a $100 million construction project, adding a new 400,000 square-foot facility to its campus of existing facilities and hiring 250 new workers in the process |
| 2021 |
Continued combating the scourge of the COVID-19 pandemic by producing testing chemicals known as reagents, as well as the test kits themselves |
| 2021 |
Partnered with Dominion Energy to open the Nephron Clinical Lab–a way to support Midlands-area residents with fast, reliable COVID-19 vaccination and testing services |
| 2021 |
Developed a new wing of existing Nephron facilities where manufacturers can focus on the creation of life-saving antibiotics and chemotherapy drugs |
| 2021 |
Announced a new syringe and equipment manufacturing venture, Inject EZ |
| 2021 |
Partnered with the ISPE Foundation to launch a new internship program, which aims to diversify Nephron’s ever-growing employee base |
| 2022 |
Nephron 503B launched a new, innovative syringe presentation – the Cyclic Olefin Copolymer (COC) syringe |
| 2022 |
Owner and CEO Lou Kennedy received a National Manufacturing Icon Award from the National Association of Manufacturers (NAM) |
